260 related articles for article (PubMed ID: 33498295)
41. Review: Do engineered nanoparticles pose a significant threat to the aquatic environment?
Scown TM; van Aerle R; Tyler CR
Crit Rev Toxicol; 2010 Aug; 40(7):653-70. PubMed ID: 20662713
[TBL] [Abstract][Full Text] [Related]
42. Polyester-based biodegradable plastics: an approach towards sustainable development.
Satti SM; Shah AA
Lett Appl Microbiol; 2020 Jun; 70(6):413-430. PubMed ID: 32086820
[TBL] [Abstract][Full Text] [Related]
43. Advanced applications of nanotechnology in veterinary medicine.
El-Sayed A; Kamel M
Environ Sci Pollut Res Int; 2020 Jun; 27(16):19073-19086. PubMed ID: 30547342
[TBL] [Abstract][Full Text] [Related]
44. Impact of liposomes as delivery systems in veterinary medicine.
Sallovitz JM; Zonco Menghini MI; Lanusse CE
Vet Res; 1998; 29(5):409-30. PubMed ID: 9779555
[TBL] [Abstract][Full Text] [Related]
45. Zwitterionic Polyester-Based Nanoparticles with Tunable Size, Polymer Molecular Weight, and Degradation Time.
Capasso Palmiero U; Maraldi M; Manfredini N; Moscatelli D
Biomacromolecules; 2018 Apr; 19(4):1314-1323. PubMed ID: 29522318
[TBL] [Abstract][Full Text] [Related]
46. Transformation pathways and fate of engineered nanoparticles (ENPs) in distinct interactive environmental compartments: A review.
Abbas Q; Yousaf B; Amina ; Ali MU; Munir MAM; El-Naggar A; Rinklebe J; Naushad M
Environ Int; 2020 May; 138():105646. PubMed ID: 32179325
[TBL] [Abstract][Full Text] [Related]
47. Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation.
Schneider CS; Xu Q; Boylan NJ; Chisholm J; Tang BC; Schuster BS; Henning A; Ensign LM; Lee E; Adstamongkonkul P; Simons BW; Wang SS; Gong X; Yu T; Boyle MP; Suk JS; Hanes J
Sci Adv; 2017 Apr; 3(4):e1601556. PubMed ID: 28435870
[TBL] [Abstract][Full Text] [Related]
48. Elimination Pathways of Nanoparticles.
Poon W; Zhang YN; Ouyang B; Kingston BR; Wu JLY; Wilhelm S; Chan WCW
ACS Nano; 2019 May; 13(5):5785-5798. PubMed ID: 30990673
[TBL] [Abstract][Full Text] [Related]
49. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
Dilnawaz F
Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
[TBL] [Abstract][Full Text] [Related]
50. Green synthesis, characterization and drug delivery applications of a novel silver/carboxymethylcellulose - poly(acrylamide) hydrogel nanocomposite.
Gulsonbi M; Parthasarathy S; Bharat Raj K; Jaisankar V
Ecotoxicol Environ Saf; 2016 Dec; 134(Pt 2):421-426. PubMed ID: 26546239
[TBL] [Abstract][Full Text] [Related]
51. Biodegradable Magnesium-Incorporated Poly(l-lactic acid) Microspheres for Manipulation of Drug Release and Alleviation of Inflammatory Response.
Yang F; Niu X; Gu X; Xu C; Wang W; Fan Y
ACS Appl Mater Interfaces; 2019 Jul; 11(26):23546-23557. PubMed ID: 31252468
[TBL] [Abstract][Full Text] [Related]
52. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
[TBL] [Abstract][Full Text] [Related]
53. Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery.
Benhabbour SR; Kovarova M; Jones C; Copeland DJ; Shrivastava R; Swanson MD; Sykes C; Ho PT; Cottrell ML; Sridharan A; Fix SM; Thayer O; Long JM; Hazuda DJ; Dayton PA; Mumper RJ; Kashuba ADM; Victor Garcia J
Nat Commun; 2019 Sep; 10(1):4324. PubMed ID: 31541085
[TBL] [Abstract][Full Text] [Related]
54. Stability of engineered nanomaterials in complex aqueous matrices: Settling behaviour of CeO2 nanoparticles in natural surface waters.
Van Koetsem F; Verstraete S; Van der Meeren P; Du Laing G
Environ Res; 2015 Oct; 142():207-14. PubMed ID: 26164115
[TBL] [Abstract][Full Text] [Related]
55. Polymeric-based drug delivery systems for veterinary use: State of the art.
Carvalho SG; Silvestre ALP; Martins Dos Santos A; Fonseca-Santos B; Rodrigues WD; Palmira Daflon Gremião M; Chorilli M; Villanova JCO
Int J Pharm; 2021 Jul; 604():120756. PubMed ID: 34058307
[TBL] [Abstract][Full Text] [Related]
56. Behavior of engineered nanoparticles in aquatic environmental samples: Current status and challenges.
Bathi JR; Moazeni F; Upadhyayula VKK; Chowdhury I; Palchoudhury S; Potts GE; Gadhamshetty V
Sci Total Environ; 2021 Nov; 793():148560. PubMed ID: 34328971
[TBL] [Abstract][Full Text] [Related]
57. In vitro anti-leukemic assessment and sustained release behaviour of cytarabine loaded biodegradable polymer based nanoparticles.
Jan N; Madni A; Rahim MA; Khan NU; Jamshaid T; Khan A; Jabar A; Khan S; Shah H
Life Sci; 2021 Feb; 267():118971. PubMed ID: 33385406
[TBL] [Abstract][Full Text] [Related]
58. SiRNA drug delivery by biodegradable polymeric nanoparticles.
Yuan X; Li L; Rathinavelu A; Hao J; Narasimhan M; He M; Heitlage V; Tam L; Viqar S; Salehi M
J Nanosci Nanotechnol; 2006; 6(9-10):2821-8. PubMed ID: 17048488
[TBL] [Abstract][Full Text] [Related]
59. Physical and chemical transformations of zirconium doped ceria nanoparticles in the presence of phosphate: Increasing realism in environmental fate and behaviour experiments.
Briffa SM; Lynch I; Hapiuk D; Valsami-Jones E
Environ Pollut; 2019 Sep; 252(Pt B):974-981. PubMed ID: 31252136
[TBL] [Abstract][Full Text] [Related]
60. Nanoparticulate Drug Delivery to Colorectal Cancer: Formulation Strategies and Surface Engineering.
Tran TT; Tran PH; Wang Y; Li P; Kong L
Curr Pharm Des; 2016; 22(19):2904-12. PubMed ID: 26898738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
